Form 8-K · Current report
Rollins, Inc. 8-K, filed Jul 22, 2026
- Filed
- CIK
- 0000084839
- Accession no.
- 0000084839-26-000038
Summary
Rollins, Inc. reported unaudited financial results for the second quarter of 2026, achieving revenues of $1.1 billion, an increase of 7.9% over the prior year. Management noted that operating margins were below expectations due to slower growth in consumer-initiated pest control segments and softer demand trends, while noting solid growth in relationship-based channels.
Key points
- Rollins, Inc. reported second-quarter revenues of $1.1 billion, representing a 7.9% increase over Q2 2025.
- Quarterly operating income was $201 million, but the operating margin decreased by 110 basis points year-over-year.
- The company attributed sub-par margin performance to softened demand and the timing of peak season.
- Management stated they are implementing organizational and operational changes to improve local execution and align resources with current demand conditions.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. On July 22, 2026, Rollins, Inc. (the “Company”) issued a press release announcing its unaudited financial results for the second quarter ended June 30, 2026. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 2.02, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.